Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and Hospital-acquired pneumonia

Clinical Infectious Diseases

Volumn 51, Issue SUPPL. 1, 2010, Pages

  Muscedere, John G ^a,b   Day, Andrew ^b   Heyland, Daren K ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; PRIORITY JOURNAL; SAMPLE SIZE; SYSTEMATIC REVIEW; VENTILATOR ASSOCIATED PNEUMONIA; BIOASSAY; CLINICAL TRIAL (TOPIC); CROSS INFECTION; HOSPITAL; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; SURVIVAL; TIME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; CROSS INFECTION; ENDPOINT DETERMINATION; HOSPITALS; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT;

EID: 77955681857     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653060     Document Type: Conference Paper

References (40)

1. Hebert P, Cook D, Wells G, et al. The design of randomized clinical trials in critically ill patients. Chest 2002; 121:1290-1300.
2. Petros AJ, Marshall JC, van Saene HK. Should morbidity replace mortality as an endpoint for clinical trials in intensive care? Lancet 1995; 345:369-371.
3. Schumacher M, Wangler M, Wolkewitcz M, et al. Attributable mortality due to nosocomial infections: a simple and useful application of mul-tistate models. Methods Inf Med 2007; 46:595-600.
4. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433-440.
5. Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33(10):2184-2193.
6. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290:2588-2598.
7. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355(25):2619-2630.
8. Aarts MA, Hancock JN, Heyland D, et al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials. Crit Care Med 2008; 36:108-117.
9. Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care 2008; 23: 91-100.
10. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
11. Ibrahim EH, Tracy L, Hill C, et al. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001; 120:555-561.
12. Tejada Artigas A, Bello Dronda S, Chacon Valles E, et al. Risk factors for nosocomial pneumonia in critically ill trauma patients. Crit Care Med 2001; 29:304-309.
13. Moine P, Timsit JF, De Lassence A, et al. Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study. Intensive Care Med 2002; 28:154-163.
14. Kanafani ZA, Kara L, Hayek S, et al. Ventilator-associated pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorganisms. Infect Control Hosp Epidemiol 2003; 24:864-869.
15. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31:1312-1317.
16. Alp E, Guven M, Yildiz O, et al. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann Clin Microbiol Antimicrob 2004; 3:17.
17. Myny D, Depuydt P, Colardyn F, et al. Ventilator-associated pneumonia in a tertiary care ICU: Analysis of risk factors for acquisition and mortality. Acta Clinica Belgica 2005; 60:114-121.
18. Noor A, Hussain SF. Risk factors associated with development of ventilator associated pneumonia. J Coll Physicians Surg Pak 2005; 15: 92-95.
19. Moreno CA, Rosenthal VD, Olarte N, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2006; 27:349-356.
20. Hyllienmark P, Gardlund B, Persson JO, et al. Nosocomial pneumonia in the ICU: a prospective cohort study. Scand J Infect Dis 2007; 39: 676-682.
21. Suka M, Yoshida K, Uno H, et al. Incidence and outcomes of ventilator-associated pneumonia in Japanese intensive care units: the Japanese nosocomial infection surveillance system. Infect Control Hosp Epidemiol 2007; 28:307-313.
22. Valles J, Pobo A, Garcia-Esquirol O, et al. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 2007; 33:1363-1368.
23. van der Kooi TI, de Boer AS, Mannien J, et al. Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 2007; 33:271-278.
24. Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, et al. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica 2008; 24:16-24.
25. da Rocha L, de A, Vilela CAP, et al. Ventilator-associated pneumonia in an adult clinical-surgical intensive care unit of a Brazilian University Hospital: incidence, risk factors, etiology, and antibiotic resistance. Braz J Infect Dis 2008; 12:80-85.
26. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288.
27. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996; 153:343-349.
28. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154:91-97.
29. Leroy O, Guilley J, Georges H, et al. Effect of hospital-acquired ventilator-associated pneumonia on mortality of severe community-acquired pneumonia. J Crit Care 1999; 14:12-19.
30. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-1256.
31. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29:2303-2309.
32. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121.
33. Leone M, Bourgoin A, Giuly E, et al. Influence on outcome of ventilator-associated pneumonia in multiple trauma patients with head trauma treated with selected digestive decontamination. Crit Care Med 2002; 30:1741-1746.
34. Rincon-Ferrari MD, Flores-Cordero JM, Leal-Noval SR, et al. Impact of ventilator-associated pneumonia in patients with severe head injury. J Trauma 2004; 57:1234-1240.
35. Cocanour CS, Ostrosky-Zeichner L, Peninger M, et al. Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit. Surg Infect (Larchmt) 2005; 6(1):65-72.
36. Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 2005; 128: 1650-1656.
37. Kallel H, Chelly H, Bahloul M, et al. The effect of ventilator-associated pneumonia on the prognosis of head trauma patients. J Trauma 2005; 59:705-710.
38. Cavalcanti M, Ferrer M, Ferrer R, et al. Risk and prognostic factors of ventilator-associated pneumonia in trauma patients. Crit Care Med 2006; 34:1067-1072.
39. Tejerina E, Frutos-Vivar F, Restrepo MI, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 2006; 21:56-65.
40. Beyersmann J, Gastmeier P, et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006; 27:493-499.